WUXIF (Wuxi AppTec Co) Earnings per Share (Diluted): $1.06 (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WUXIF Wuxi AppTec Co Ltd WUXIF
81 GF Score
Price $25.32
GF Value $16.82
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Wuxi AppTec Co Earnings per Share (Diluted)?

Wuxi AppTec Co WUXIF 81 Earnings per Share (Diluted) is $1.06 as of Jun. 2026. GuruFocus rates WUXIF with a GF Score™ of 81/100 and a GF Value™ of $16.82 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 157 Medical Diagnostics & Research companies, Wuxi AppTec Co ranks better than 57.96% on this metric.

Wuxi AppTec Co's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was $0.32. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was $1.06.

Wuxi AppTec Co's EPS (Basic) for the three months ended in Jun. 2026 was $0.33. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $1.08.

Wuxi AppTec Co's EPS without NRI for the three months ended in Jun. 2026 was $0.32. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was $1.06.

During the past 12 months, Wuxi AppTec Co's average EPS without NRIGrowth Rate was 37.50% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 17.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 38.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 35.40% per year.

During the past 12 years, Wuxi AppTec Co's highest 3-Year average EPS without NRI Growth Rate was 59.50% per year. The lowest was 11.30% per year. And the median was 35.60% per year.


Wuxi AppTec Co  (OTCPK:WUXIF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Wuxi AppTec Co Earnings per Share (Diluted) Related Terms


Wuxi AppTec Co Earnings per Share (Diluted) Historical Data

* Premium members only.

The historical data trend for Wuxi AppTec Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wuxi AppTec Co Earnings per Share (Diluted) Chart

Wuxi AppTec Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.40 0.45 0.45 0.94

Wuxi AppTec Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.17 0.34 0.23 0.32

WUXIF vs TMO, DHR, IDXX: Earnings per Share (Diluted) Comparison

For the Diagnostics & Research subindustry, Wuxi AppTec Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's PE Ratio falls into.


WUXIF
81GF Score
Wuxi AppTec Co Ltd WUXIF
Earnings per Share (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wuxi AppTec Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Wuxi AppTec Co's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as

Diluted Earnings Per Share (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(2719.017-0)/2897.214
=0.94

Wuxi AppTec Co's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2026 is calculated as

Diluted Earnings Per Share (Q: Jun. 2026 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(948.767-0)/2949.711
=0.32

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

What does a Earnings per Share (Diluted) of $1.06 mean?
Wuxi AppTec Co (WUXIF) has a Earnings per Share (Diluted) of $1.06 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Wuxi AppTec Co and its competitors. According to the industry distribution chart, Wuxi AppTec Co ranks #66 out of 157 companies in the Medical Diagnostics & Research industry, placing it in the top 42%.
Is Wuxi AppTec Co's Earnings per Share (Diluted) too high?
Wuxi AppTec Co's current Earnings per Share (Diluted) is $1.06. The Medical Diagnostics & Research industry median Earnings per Share (Diluted) is 10.80. Wuxi AppTec Co's value of $1.06 is 90.2% below this industry median. Based on the distribution chart, Wuxi AppTec Co ranks #66 out of 157 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Wuxi AppTec Co has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's Earnings per Share (Diluted) compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Wuxi AppTec Co ranks #66 out of 157 companies for Earnings per Share (Diluted). This puts Wuxi AppTec Co in the upper half of its industry. The industry median Earnings per Share (Diluted) is 10.80. Wuxi AppTec Co's value of $1.06 is 90.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Diagnostics & Research company?
The median Earnings per Share (Diluted) among Medical Diagnostics & Research companies is 10.80, based on 157 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wuxi AppTec Co's current Earnings per Share (Diluted) of $1.06 is 90.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Wuxi AppTec Co and its competitors. For the Medical Diagnostics & Research industry, the median Earnings per Share (Diluted) is 10.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wuxi AppTec Co's current Earnings per Share (Diluted) is $1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (WUXIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $16.82, compared to a current price of $25.32 — trading 50.5% above its estimated fair value. The current Earnings per Share (Diluted) is $1.06 and 90.2% below the Medical Diagnostics & Research industry median of 10.80. Wuxi AppTec Co's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Wuxi AppTec Co (WUXIF), the current Earnings per Share (Diluted) is $1.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?

Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued. The current stock price of $25.32 is trading 50.5% above its estimated GF Value™ of $16.82. GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.

Key valuation signals for WUXIF:

  • Earnings per Share (Diluted): $1.06
  • GF Value™: $16.82 vs. price of $25.32 (50.5% above fair value)
  • GF Score™: 81/100 with 6 warning signs
  • Industry Position: 90.2% below the Medical Diagnostics & Research median (#66 of 157)

No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Wuxi AppTec Co Business Description

Address 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
81GF Score

Get the complete analysis for WUXIF

Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.32
Price
$16.82
GF Value